Regular Article
Differential Mononuclear Leukocyte Attracting Chemokine Production after Stimulation with Active and Inactivated Influenza A Virus

https://doi.org/10.1006/cimm.1998.1295Get rights and content

Abstract

After influenza A virus infection of human monocytes, we found a rapid and marked release of the mononuclear cell attracting chemokines MCP-1, MIP-1α, and IP-10, with corresponding gene expression patterns as determined by Northern blot analysis. In striking contrast, the expression and release of the neutrophil chemoattractant IL-8 was not inducible. To determine the underlying mechanisms responsible for the induction of this differential chemokine pattern, we stimulated monocytes with UV- and heat-inactivated (56°C and 100°C) influenza A virus. In comparison with fully infectious influenza A, 56°C-inactivated virus induced a strong production of MCP-1, MIP-1α, and IP-10, while the release of MIP-1α and IP-10 was substantially lower after exposure to UV-inactivated virus. No chemokine expression was found after stimulation with 100°C-inactivated influenza A virus. Our data indicate that, contingent upon the chemokine examined, the maximal induction depends on the unrestricted infectivity of the virus, the unaltered hemagglutinin molecule, or the intact viral RNA. This diversified chemokine production may enable the infected host to mount an efficient antiviral response against infective and noninfective virus particles.

References (43)

  • B.A. Imhof et al.

    Adv. Immunol.

    (1995)
  • T.J. Schall

    Cytokine

    (1991)
  • H.-D. Klenk et al.

    Virology

    (1975)
  • H. Sprenger et al.

    Clin. Immunol. Immunopathol.

    (1996)
  • H. Sprenger et al.

    BioTechniques

    (1995)
  • R.T.C. Huang et al.

    Virology

    (1981)
  • A.M.K. Choi et al.

    FEBS Lett.

    (1992)
  • D. Aderka et al.

    J. Immunol.

    (1986)
  • N.J. Roberts et al.

    J. Exp. Med.

    (1986)
  • A.E. Goldfeld et al.

    Proc. Natl. Acad. Sci. USA

    (1989)
  • L. Dudding et al.

    J. Immunol.

    (1989)
  • J.-M. Molina et al.

    J. Clin. Invest.

    (1989)
  • E.C. Breen et al.

    J. Immunol.

    (1990)
  • F. Vacheron et al.

    J. Gen. Virol.

    (1990)
  • M. Nain et al.

    J. Immunol.

    (1990)
  • J.-H. Gong et al.

    J. Immunol.

    (1991)
  • A. Henke et al.

    J. Immunol.

    (1992)
  • A. Bender et al.

    J. Immunol.

    (1993)
  • H. Sprenger et al.

    J. Immunol.

    (1994)
  • H. Sprenger et al.

    J. Exp. Med.

    (1996)
  • J.J. Oppenheim et al.

    Annu. Rev. Immunol.

    (1991)
  • Cited by (62)

    • Responses of human mast cells and epithelial cells following exposure to influenza A virus

      2019, Antiviral Research
      Citation Excerpt :

      Despite advances in vaccine development and other health care improvements regarding infectious diseases, influenza affects millions of individuals annually and pandemics, such as that of H1N1 in 2009, remain a major concern. FluA primarily infects and replicates within airway epithelial cells (EC), but host defences against influenza involve many cell types, including monocytes (Bussfeld et al., 1998), dendritic cells (Hao et al., 2008), eosinophils (Samarasinghe et al., 2017) and neutrophils (Wang et al., 2008). By investigating the response of different cell types to FluA infection, we can gain a better understanding of the mechanisms of host resistance and viral clearance.

    • Influenza A virus induction of oxidative stress and MMP-9 is associated with severe lung pathology in a mouse model

      2013, Virus Research
      Citation Excerpt :

      Here we showed that CXCL6/GCP-2 is produced in the lungs after infection by WSN influenza virus, and that there is Gr-1+ cell infiltration (Figs. 3B and 4B). CCL2/MCP-1 is a potent chemoattractant for monocytes (Adachi et al., 1997; Bussfeld et al., 1998). In WSN virus-infected mice there is a high level of CCL2/MCP-1 and persistently high numbers of CD11b+ cells in the lungs (Figs. 3A and 4).

    • Review: Influenza virus in pigs

      2013, Molecular Immunology
      Citation Excerpt :

      IVs are thought to infect mainly the respiratory-tract epithelial cells of animals and humans in vivo. IVs are able to infect a variety of cells in vitro, including the Madin-Darby canine kidney (MDCK) cell line (Tobita et al., 1975), the African Green Monkey Kidney (VERO) cell line (Genzel et al., 2010), human monocytes (Bussfeld et al., 1998) and human monocyte-derived macrophages (Hofmann et al., 1997). Several in vitro studies have investigated the interaction between IV and different systems of mammalian cells.

    • Trivalent influenza vaccine and febrile adverse events in australia, 2010: Clinical features and potential mechanisms

      2011, Vaccine
      Citation Excerpt :

      In this regard, we detected significantly higher levels of the chemokine IP-10 (CXCL10) in cases. IP-10 has been implicated in immune response to several viruses, including influenza A14, and was recently shown to be a useful biomarker of respiratory infection itself.17 The chemokine also serves as a useful biomarker of human IFN-β responses and strongly correlates with febrile responses in multiple sclerosis patients treated with recombinant IFN-β.18

    • Gene expression changes in the host response between resistant and susceptible inbred mouse strains after influenza A infection

      2010, Microbes and Infection
      Citation Excerpt :

      Amongst them, the Ccr5 gene showed up-regulation of almost 8-fold in both strains, whereas Ccr1, Csf3r, Il1r2 and Ccr2 were up-regulated more than 4-fold only in DBA/2J mice (Fig. 1C). Infected respiratory epithelial cells and alveolar macrophages are thought to represent the main cell populations for the early release of Ccl2, Ccl5, Ccl3, Ccl4, Cxcl8 and Cxcl10 [24–29]. A strong induction of chemokines and cytokines was also observed in mice infected with the high pathogenic 1918 virus [8,9] and the H5N1 virus [30,31] and were associated with unfavorable disease outcome [4,32].

    View all citing articles on Scopus

    B. N. FieldsD. M. Knipe

    1

    Present address: Institute of Laboratory Medicine, Leopoldina-Hospital, Gustav-Adolf-Str. 8, D-97422 Schweinfurt, Germany.

    View full text